Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.98 USD | +5.15% | +3.22% | +46.25% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
Financials (USD)
Sales 2024 * | 3.62M | Sales 2025 * | 4.94M | Capitalization | 322M |
---|---|---|---|---|---|
Net income 2024 * | -95M | Net income 2025 * | -120M | EV / Sales 2024 * | 47.6 x |
Net cash position 2024 * | 150M | Net cash position 2025 * | 67.4M | EV / Sales 2025 * | 51.6 x |
P/E ratio 2024 * |
-3.15
x | P/E ratio 2025 * |
-3.09
x | Employees | 88 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.92% |
Latest transcript on Solid Biosciences Inc.
1 day | +5.15% | ||
1 week | +3.22% | ||
Current month | -32.58% | ||
1 month | -33.82% | ||
3 months | +12.53% | ||
6 months | +349.00% | ||
Current year | +46.25% |
Managers | Title | Age | Since |
---|---|---|---|
Annie Ganot
FOU | Founder | - | 13-02-28 |
Ilan Ganot
FOU | Founder | 50 | 13-02-28 |
Alexander Cumbo
CEO | Chief Executive Officer | 53 | 22-09-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Smith
CHM | Chairman | 58 | 20-04-14 |
Martin Freed
BRD | Director/Board Member | 63 | 18-06-25 |
Raj Shah
BRD | Director/Board Member | 46 | 17-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 8.98 | +5.15% | 189,872 |
24-04-25 | 8.54 | -2.62% | 378,947 |
24-04-24 | 8.77 | -3.73% | 138,410 |
24-04-23 | 9.11 | +0.77% | 297,274 |
24-04-22 | 9.04 | +3.91% | 187,755 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.25% | 322M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- SLDB Stock